Imugene Limited

IUGNF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$21-$48-$81-$69
Dep. & Amort.$2$1$0$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$6$0$0$0
Change in WC-$4$0-$3$0
Other Non-Cash-$21$8$35$18
Operating Cash Flow-$37-$39-$49-$48
Investing Activities
PP&E Inv.$3-$11$2-$11
Net Acquisitions$0$0$1$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$4-$9$1-$5
Investing Cash Flow$7-$20$5-$16
Financing Activities
Debt Repay.$0-$0$0-$0
Stock Issued$0$0$0$50
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$18$0-$1$0
Financing Cash Flow$18-$0-$1$50
Forex Effect-$0-$0-$1$1
Net Chg. in Cash-$34$34-$46-$14
Supplemental Information
Beg. Cash$34$0$139$153
End Cash$0$34$93$139
Free Cash Flow-$34-$49-$47-$60
Imugene Limited (IUGNF) Financial Statements & Key Stats | AlphaPilot